Additionally, patients with a personal or family history of medullary thyroid carcinoma should not take semaglutide
Once you understand what the goals are and what the possible benefits might be, then you will also want to talk about the risks
Thyroid labs (TSH, Free T4, Free T3) should be checked every 68 weeks when starting or adjusting GLP-1 or thyroid medications
These symptoms can reinforce continued use, creating a cycle of addiction
Indeed, lower semaglutide exposure was observed in PIONEER 3 than in the other global PIONEER trials [26]
Questions to ask any provider offering oral tirzepatide If a healthcare provider offers oral tirzepatide, ask these questions: What is the source of the tirzepatide used in this product